DK0436217T3 - Antiinflammatorisk analgetisk plaster - Google Patents

Antiinflammatorisk analgetisk plaster

Info

Publication number
DK0436217T3
DK0436217T3 DK90125524.0T DK90125524T DK0436217T3 DK 0436217 T3 DK0436217 T3 DK 0436217T3 DK 90125524 T DK90125524 T DK 90125524T DK 0436217 T3 DK0436217 T3 DK 0436217T3
Authority
DK
Denmark
Prior art keywords
reserver
drug
inflammatory analgesic
analgesic patch
acid
Prior art date
Application number
DK90125524.0T
Other languages
Danish (da)
English (en)
Inventor
Akihito Oji
Yukihiro Tada
Noriyuki Sasaki
Mitsuo Mizumura
Original Assignee
Lederle Japan Ltd
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd, Teikoku Seiyaku Kk filed Critical Lederle Japan Ltd
Application granted granted Critical
Publication of DK0436217T3 publication Critical patent/DK0436217T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK90125524.0T 1989-12-25 1990-12-27 Antiinflammatorisk analgetisk plaster DK0436217T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1332599A JP2839164B2 (ja) 1989-12-25 1989-12-25 消炎鎮痛貼付剤

Publications (1)

Publication Number Publication Date
DK0436217T3 true DK0436217T3 (da) 1995-05-01

Family

ID=18256747

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90125524.0T DK0436217T3 (da) 1989-12-25 1990-12-27 Antiinflammatorisk analgetisk plaster

Country Status (10)

Country Link
US (1) US5116621A (el)
EP (1) EP0436217B1 (el)
JP (1) JP2839164B2 (el)
KR (1) KR0180007B1 (el)
AT (1) ATE120648T1 (el)
CA (1) CA2033122C (el)
DE (1) DE69018424T2 (el)
DK (1) DK0436217T3 (el)
ES (1) ES2070261T3 (el)
GR (1) GR3015812T3 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
US5902600A (en) * 1992-12-21 1999-05-11 Healthpoint, Ltd. Hydrogel polymer wound dressing
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
US5409691A (en) * 1993-10-18 1995-04-25 Swain; Dan E. Solution comprising aluminum acetate and glycerin
AU2266995A (en) * 1994-04-21 1995-11-16 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
JPH10120560A (ja) 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
JPH10265374A (ja) * 1997-03-24 1998-10-06 Saitama Daiichi Seiyaku Kk 外用剤組成物及びその製造方法
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6211296B1 (en) 1998-11-05 2001-04-03 The B. F. Goodrich Company Hydrogels containing substances
JP4584381B2 (ja) * 1999-07-30 2010-11-17 久光製薬株式会社 フェルビナク含有貼付剤
US6698162B2 (en) 2000-03-23 2004-03-02 Teikoku Pharma Usa, Inc. Methods of producing a terminally sterilized topical patch preparation
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 ４−ビフェニル酢酸含有貼付剤
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
TWI412570B (zh) * 2004-04-27 2013-10-21 Showa Denko Kk Adhesive for patch and method for producing the same
TWI414320B (zh) * 2004-05-13 2013-11-11 Hisamitsu Pharmaceutical Co 含有非類固醇系消炎鎮痛劑之外用經皮製劑
EP3566692A1 (en) * 2006-07-21 2019-11-13 BioDelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
KR100867262B1 (ko) 2007-01-17 2008-11-06 대화제약 주식회사 펠비낙을 함유하는 플라스터 조성물
US20110319399A1 (en) * 2009-03-11 2011-12-29 Kowa Co., Ltd. External preparation containing analgesic/anti-inflammatory agent
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
SG10201610097WA (en) 2011-08-18 2017-01-27 Biodelivery Sciences Int Inc Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
JP2012144562A (ja) * 2012-04-17 2012-08-02 Teikoku Seiyaku Co Ltd 貼付剤
JP5949285B2 (ja) * 2012-07-31 2016-07-06 ライオン株式会社 貼付剤
JP6893086B2 (ja) 2013-03-13 2021-06-23 エーブリー デニソン コーポレイション 接着特性の向上
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
TWI800597B (zh) * 2018-01-30 2023-05-01 日商日東電工股份有限公司 經皮吸收型製劑

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
JPS6485913A (en) * 1987-09-26 1989-03-30 Saitama Daiichi Seiyaku Kk Anti-inflammatory analgesic plaster containing 4-biphenylylacetic acid
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel

Also Published As

Publication number Publication date
JP2839164B2 (ja) 1998-12-16
CA2033122C (en) 2003-08-19
EP0436217A3 (en) 1991-09-25
JPH03193728A (ja) 1991-08-23
US5116621A (en) 1992-05-26
DE69018424T2 (de) 1995-09-21
ATE120648T1 (de) 1995-04-15
ES2070261T3 (es) 1995-06-01
EP0436217B1 (en) 1995-04-05
CA2033122A1 (en) 1991-06-26
KR910011248A (ko) 1991-08-07
EP0436217A2 (en) 1991-07-10
KR0180007B1 (ko) 1999-03-20
GR3015812T3 (en) 1995-07-31
DE69018424D1 (de) 1995-05-11

Similar Documents

Publication Publication Date Title
DK0436217T3 (da) Antiinflammatorisk analgetisk plaster
MX9308199A (es) Inhibidores de enzima.
FR2655266B1 (fr) Compositions pharmaceutiques a base de cimetidine.
PE12697A1 (es) Compuestos heterociclicos, su preparacion y su uso
TNSN94035A1 (fr) Composition veterinaire
ATE51342T1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
FI950319A0 (fi) Säädellyn vapautumisnopeuden omaava morfiinivalmiste
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
DE69101291D1 (de) Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
ATE113839T1 (de) Arzneimittel gegen impotenz.
SE9601528D0 (sv) Transdermally administered dextromethorphan as antitissue agent
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
EP0353474A3 (en) Glycerin derivative and its pharmacological use
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
ATE96025T1 (de) Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
KR900017599A (ko) 종양 치료용 약학 조성물
ATE74505T1 (de) Schmerzpraeparat.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
KR940703656A (ko) 에이즈 바이러스 감염 저해용 조성물